KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer
Donjeta Bali: United, We Make Every Child’s Victory Possible
Call for Papers: Special Series on Cancer in the Middle East in 2026
Todd Harper: Cancer Research Giving Day Raised $671,000 Towards Cancer Research
Cherie Myatt Steps Into Interim President Role at Vaniam Group
KEYNOTE-091 (PEARLS): Adjuvant Pembrolizumab in Resected NSCLC
Hope 4 Kids Albania: Committed to Ensuring Access to Care for Every Child Fighting Cancer
Cancer Patients Invited to Share Their Experiences in Conversations About Surgery
